Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer

Terumo Blood and Cell Technologies Names Patrick Daly as Chief Business Officer

Daly, a 30-year veteran of the healthcare industry, is the latest leadership addition to help Terumo BCT unite business areas and fuel enterprise growth

Terumo Appoints Patrick Daly as Chief Business Officer

LAKEWOOD, Colo., April 17, 2025 /PRNewswire/ -- Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, today announced the addition of Patrick Daly as its Chief Business Officer as the company continues to expand its capabilities to meet evolving market segments. Daly joins Terumo BCT with over 30 years of business and healthcare industry experience, both domestically and internationally. Most recently, he built the MedTe…

Strategic Hire: Former IQVIA Executive to Drive Terumo BCT's Double-Digit Growth Vision

30-year healthcare veteran Patrick Daly brings expertise in strategic partnerships and data monetization to accelerate Terumo BCT's ambitious growth plans. Full analysis inside.